Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy M Dempsey

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Medical Education Online|April 16, 2019
Pulmonary and critical care fellowship applicants utilization of social media to evaluate programsTimothy M Dempsey, Kelly Pennington, Megan Dulohery-Scrodin, et al.
Annals of the American Thoracic Society|May 12, 2021
Reply: Adoption of Antifibrotic Medications: A Closer Look at the DataTimothy M Dempsey, Stephanie Payne, Lindsey Sangaralingham, et al.
Chest|August 5, 2023
Comparing the Utilization of Antifibrotic Medications Based on Income LevelTimothy M Dempsey, Viengneesee Thao, David Helfinstine, et al.
ATS Scholar|April 19, 2021
Miles to Go Before We Sleep. Reforming the Pulmonary and Critical Care Milestones to Improve Trainee AssessmentJanae K Heath, Timothy M Dempsey, Lekshmi Santhosh, et al.
Chest|October 5, 2024
The Impact of Nintedanib Dosing on Clinical Outcomes: An Analysis of Real-World DataAndrew H Limper, Viengneesee Thao, David A Helfinstine, et al.
BMC Pulmonary Medicine|January 10, 2022
Cost-effectiveness of the anti-fibrotics for the treatment of idiopathic pulmonary fibrosis in the United StatesTimothy M Dempsey, Viengneesee Thao, James P Moriarty, et al.
Journal of Cardiovascular Development and Disease|January 26, 2018
Management of Mechanical Ventilation in Decompensated Heart FailureBrooks T Kuhn, Laura A Bradley, Timothy M Dempsey, et al.
Annals of the American Thoracic Society|January 19, 2021
Adoption of the Antifibrotic Medications Pirfenidone and Nintedanib for Patients with Idiopathic Pulmonary FibrosisTimothy M Dempsey, Stephanie Payne, Lindsey Sangaralingham, et al.
American Journal of Respiratory and Critical Care Medicine|June 1, 2019
Clinical Effectiveness of Antifibrotic Medications for Idiopathic Pulmonary FibrosisTimothy M Dempsey, Lindsey R Sangaralingham, Xiaoxi Yao, et al.
BMJ Open|March 19, 2021
Association of outpatient ACE inhibitors and angiotensin receptor blockers and outcomes of acute respiratory illness: a retrospective cohort studyMolly Moore Jeffery, Nathan W Cummins, Timothy M Dempsey, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Medical Education Online|April 16, 2019
Pulmonary and critical care fellowship applicants utilization of social media to evaluate programsTimothy M Dempsey, Kelly Pennington, Megan Dulohery-Scrodin, et al.
Annals of the American Thoracic Society|May 12, 2021
Reply: Adoption of Antifibrotic Medications: A Closer Look at the DataTimothy M Dempsey, Stephanie Payne, Lindsey Sangaralingham, et al.
Chest|August 5, 2023
Comparing the Utilization of Antifibrotic Medications Based on Income LevelTimothy M Dempsey, Viengneesee Thao, David Helfinstine, et al.
ATS Scholar|April 19, 2021
Miles to Go Before We Sleep. Reforming the Pulmonary and Critical Care Milestones to Improve Trainee AssessmentJanae K Heath, Timothy M Dempsey, Lekshmi Santhosh, et al.
Chest|October 5, 2024
The Impact of Nintedanib Dosing on Clinical Outcomes: An Analysis of Real-World DataAndrew H Limper, Viengneesee Thao, David A Helfinstine, et al.
BMC Pulmonary Medicine|January 10, 2022
Cost-effectiveness of the anti-fibrotics for the treatment of idiopathic pulmonary fibrosis in the United StatesTimothy M Dempsey, Viengneesee Thao, James P Moriarty, et al.
Journal of Cardiovascular Development and Disease|January 26, 2018
Management of Mechanical Ventilation in Decompensated Heart FailureBrooks T Kuhn, Laura A Bradley, Timothy M Dempsey, et al.
Annals of the American Thoracic Society|January 19, 2021
Adoption of the Antifibrotic Medications Pirfenidone and Nintedanib for Patients with Idiopathic Pulmonary FibrosisTimothy M Dempsey, Stephanie Payne, Lindsey Sangaralingham, et al.
American Journal of Respiratory and Critical Care Medicine|June 1, 2019
Clinical Effectiveness of Antifibrotic Medications for Idiopathic Pulmonary FibrosisTimothy M Dempsey, Lindsey R Sangaralingham, Xiaoxi Yao, et al.
BMJ Open|March 19, 2021
Association of outpatient ACE inhibitors and angiotensin receptor blockers and outcomes of acute respiratory illness: a retrospective cohort studyMolly Moore Jeffery, Nathan W Cummins, Timothy M Dempsey, et al.
Pageof 3